Building Quality into Biologic Production to Meet Regulations
A look at how the industry is focusing on quality and sterility into DPs to ensure patient safety in the pharmaceutical industry.
Stay updated with breaking news from Retrieved August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A look at how the industry is focusing on quality and sterility into DPs to ensure patient safety in the pharmaceutical industry.
– Merger to create NASDAQ-listed, commercial-stage AI-Enabled medical technology company focused on bringing FDA-cleared Brain Network Analytics platform...
Pharmacists are accessible and trusted health care professionals who have an important role in supporting people living with mental illness.
SCHLIEREN, Switzerland, October 09, 2023--LimmaTech Biologics AG today announced the closing of a USD 37 million (CHF 33 million) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund. The proceeds will enable LimmaTech to advance its proprietary technology platform and accelerate its pipeline of preclinical and clinical vaccine candidates against increasingly dangerous bacterial infections, including programs addressing shigellosis and gonorr
SCHLIEREN, Switzerland--(BUSINESS WIRE)--LimmaTech Biologics AG today announced the closing of a USD 37 million (CHF 33 million) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund. The proceeds will enable LimmaTech to advance its proprietary technology platfor...